Inhibitor of nitric oxide synthase (NOS).
Product Details
| Formula: | CH7N4 . HCO3 |
| |
| MW: | 75.1 . 61.0 |
| |
| CAS: | 2582-30-1 |
| |
| MI: | 14: 441 |
| |
| RTECS: | FG1772000 |
| |
| Purity: | ≥97% (Assay) |
| |
| Appearance: | White to off-white solid. |
| |
| Solubility: | Soluble in water. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | +4°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Selective inhibition of inducible nitric oxide synthase by aminoguanidine: J.A. Corbett & M.L. McDaniel; Methods Enzymol.
268, 398 (1996),
Abstract;
Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo: F. Laszlo, et al.; Eur. J. Pharmacol.
272, 169 (1995),
Abstract;
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice: A.H. Cross, et al.; J. Clin. Invest.
93, 2684 (1994),
Abstract;
Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta: G.A. Joly, et al.; BBRC
199, 147 (1994),
Abstract;
Aminoguanidine selectively inhibits inducible nitric oxide synthase: M.J. Griffiths, et al.; Br. J. Pharmacol.
110, 963 (1993),
Abstract;
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine: T.P. Misko, et al.; Eur. J. Pharmacol.
233, 119 (1993),
Abstract;
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction: J.A. Corbett, et al.; Diabetes
41, 552 (1992),
Abstract;
